Monday, March 9, 2026
$1.1M NOHFC grant accelerates Sudbury-based cancer innovation with global impact
GREATER SUDBURY, ON – A $1.1-million investment from the Ontario government through the Northern Ontario Heritage Fund Corporation is accelerating groundbreaking cancer research and innovation taking place right here in Sudbury.
This important support, totalling $1,157,000 strengthens the work of Rna Diagnostics, a clinical-stage molecular diagnostics company operating its laboratory at Health Sciences North Research Institute (HSNRI), as it advances toward commercialization of its Veridapt DX test platform, reinforcing Northeastern Ontario’s growing leadership in health innovation.
Veridapt DX is designed to help oncologists determine early in treatment whether chemotherapy is effectively destroying a patient’s tumour. By measuring RNA disruption, a biological signal that indicates tumour response, physicians may be able to identify patients who are not responding to therapy and adjust care sooner, potentially reducing unnecessary side effects and...